MedTrace Logo

CLEAR Clinical Study

NCT03126825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2018-01-17

No results posted yet for this study

Summary

Acute in-booth assessment of a new noise reduction algorithm with cochlear implant recipients.

Conditions

Interventions

DEVICE

CP910/CP920 with noise reduction on

This intervention uses the approved Nucleus 6 system (CP910/CP920 and accessories) but adds the investigational noise reduction algorithm.

DEVICE

CP910/CP920

The approved CP910 or CP920 Sound Processor.

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Mary Beth Brinson, Phd · Head of Global Clinical Affairs

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2017-08-13
Completion
2017-09-01

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126825 on ClinicalTrials.gov